These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23058852)

  • 41. A-ring modification of SCH 900229 and related chromene sulfone γ-secretase inhibitors.
    Wu WL; Sasikumar TK; Domalski MS; Qiang L; Burnett DA; Clader J; Greenlee WJ; Chan TM; Lee J; Zhang L
    Bioorg Med Chem Lett; 2013 Feb; 23(3):850-3. PubMed ID: 23265902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring Bioisostere.
    Rodríguez Sarmiento RM; Bissantz C; Bylund J; Limberg A; Neidhart W; Jakob-Roetne R; Wang L; Baumann K
    J Med Chem; 2020 Aug; 63(15):8534-8553. PubMed ID: 32706964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of the γ-Secretase Modulator MK-8428.
    Miller SP; Morris WJ; Orr RK; Eckert J; Milan J; Maust M; Cowden C; Cui J
    J Org Chem; 2017 Mar; 82(6):2957-2964. PubMed ID: 28262021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Local Desymmetrization Approach to Piperidinyl Acetic Acid γ-Secretase Modulators.
    Cheng P; Lu H; Zu L
    J Org Chem; 2021 Nov; 86(21):15481-15487. PubMed ID: 34641679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside.
    Fuller NO; Hubbs JL; Austin WF; Creaser SP; McKee TD; Loureiro RM; Tate B; Xia W; Ives JL; Findeis MA; Bronk BS
    ACS Med Chem Lett; 2012 Nov; 3(11):908-13. PubMed ID: 24900406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presence of soluble and cell-surface B-cell maturation antigen in systemic light-chain amyloidosis and its modulation by gamma-secretase inhibition.
    Godara A; Zhou P; Kugelmass A; Ma X; Rosenthal B; Toskic D; Fogaren T; Varga C; Comenzo RL
    Am J Hematol; 2020 May; 95(5):E110-E113. PubMed ID: 31951032
    [No Abstract]   [Full Text] [Related]  

  • 47. Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy.
    Pettersson M; Johnson DS; Rankic DA; Kauffman GW; Am Ende CW; Butler TW; Boscoe B; Evrard E; Helal CJ; Humphrey JM; Stepan AF; Stiff CM; Yang E; Xie L; Bales KR; Hajos-Korcsok E; Jenkinson S; Pettersen B; Pustilnik LR; Ramirez DS; Steyn SJ; Wood KM; Verhoest PR
    Medchemcomm; 2017 Apr; 8(4):730-743. PubMed ID: 30108792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease.
    Ratni H; Baumann K; Bellotti P; Cook XA; Green LG; Luebbers T; Reutlinger M; Stepan AF; Vifian W
    RSC Med Chem; 2021 May; 12(5):758-766. PubMed ID: 34124674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switched Aβ43 generation in familial Alzheimer's disease with presenilin 1 mutation.
    Kakuda N; Takami M; Okochi M; Kasuga K; Ihara Y; Ikeuchi T
    Transl Psychiatry; 2021 Nov; 11(1):558. PubMed ID: 34728605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.
    Moriya M; Miyajima M; Nakajima M; Ogino I; Arai H
    PLoS One; 2015; 10(3):e0119973. PubMed ID: 25821958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase.
    Funamoto S; Sasaki T; Ishihara S; Nobuhara M; Nakano M; Watanabe-Takahashi M; Saito T; Kakuda N; Miyasaka T; Nishikawa K; Saido TC; Ihara Y
    Nat Commun; 2013; 4():2529. PubMed ID: 24108142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease.
    Wahlster L; Arimon M; Nasser-Ghodsi N; Post KL; Serrano-Pozo A; Uemura K; Berezovska O
    Acta Neuropathol; 2013 Feb; 125(2):187-99. PubMed ID: 23138650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suspected limited efficacy of γ-secretase modulators.
    Kakuda N; Akazawa K; Hatsuta H; Murayama S; Ihara Y;
    Neurobiol Aging; 2013 Apr; 34(4):1101-4. PubMed ID: 23058852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gamma-secretase inhibitors in Alzheimer's disease therapy].
    Katarína S; Jan K; Kamil K; Kamil M
    Ceska Slov Farm; 2012 Jun; 61(3):93-100. PubMed ID: 22913824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.